MICOT PHARMA-B 02335·

ROE 36.33%---138.30%174.62%18.77%157.07% ROA -58.13%---63.43%5.30%-55.79%7.64% Attributable profit growth ----17.46%---18.03%35.48% Debt-to-assets 248.28%--48.72%199.56%389.59%340.87% Current ratio 4.36--2.391.970.981.40 Operating cash flow / net profit 0.51--0.690.170.740.05

Attributable profit growth -----372.08%-- Current ratio ----9.11-- Operating cash flow / net profit 1.05---0.471.52

Other income and gains 6.97M--4.00M42.57%2.30M42.50% Administrative expenses 18.00M--18.81M4.49%23.49M24.87% Net finance costs 100.42M--37.65M62.51%67.00M77.98% Income tax 37.00K--24.00K35.14%---- Operating profit -94.98M---119.16M25.46%-117.91M1.05% Profit before tax -195.40M---156.81M19.75%-184.91M17.92% Net profit -195.44M---156.83M19.75%-184.91M17.91% Net profit attributable to owners -187.33M---154.63M17.46%-182.51M18.03%

Other income and gains 1.22M--1.33M9.25% Administrative expenses 8.85M--33.14M274.56% Net finance costs 1.41M--67.11M4653.19% Income tax 0--0-- Profit before tax -49.90M---231.68M364.28% Net profit -49.90M---231.68M364.28% Net profit attributable to owners -48.90M---230.82M372.08%

Cash and cash equivalents 95.94M--64.66M32.60%80.56M24.58% Total current assets 299.93M--185.98M37.99%262.20M40.99% Total assets 336.20M--247.26M26.46%331.46M34.05% Total current liabilities 68.80M--77.93M13.28%266.41M241.85% Total liabilities 834.71M--120.47M85.57%1.29B971.97% Equity attributable to owners -515.70M--111.81M121.68%-972.46M969.74% Total equity -498.51M--126.79M125.43%-959.88M857.05%

Cash and cash equivalents ----1.07B-- Total current assets ----1.21B-- Total current liabilities ----132.66M-- Equity attributable to owners ----945.34M-- Total equity ----957.06M--

Net cash from operating activities -100.65M---107.74M7.05%-137.13M27.28% Net cash from investing activities 21.21M--54.80M158.36%-57.58M205.07% Net cash from financing activities 102.00M--21.12M79.29%212.24M904.76% Net change in cash 22.57M---31.82M240.96%17.52M155.08%

Net cash from operating activities -52.29M--109.17M308.77% Net cash from investing activities 51.48M--32.40M37.06% Net cash from financing activities 43.38M--847.45M1853.73% Net change in cash 42.56M--989.03M2223.79%